BioCryst & Celgene Suffer English Funding Setback For Rare Disease Drugs

NICE’s Recommendations Are Out For Consultation until 28 July

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".